enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Antianginal - Wikipedia

    en.wikipedia.org/wiki/Antianginal

    Alongside these lifestyle changes, the use of antianginal drugs is a common approach. However, findings from randomized controlled trials reveal that the efficacy of various antianginal drugs is comparable, with none demonstrating a significant reduction in mortality or the risk of myocardial infarction (MI). Despite this, prevailing guidelines ...

  3. Angiogenesis inhibitor - Wikipedia

    en.wikipedia.org/wiki/Angiogenesis_inhibitor

    Thalidomide is one such antiangiogenic agent. Thalidomide was given to pregnant women to treat nausea. Thalidomide was given to pregnant women to treat nausea. However, when pregnant women take an antiangiogenic agent, the developing fetus will not form blood vessels properly, thereby preventing the proper development of fetal limbs and ...

  4. Ethinylestradiol/cyproterone acetate - Wikipedia

    en.wikipedia.org/wiki/Ethinylestradiol/cyprotero...

    CPA/EE-containing birth control pills were developed by 1975 [20] [21] and were first introduced for medical use in 1978. [22] They originally contained 50 μg EE (Diane); subsequently, the EE dosage was decreased to 35 μg in a new "low-dose" preparation in 1986 (Diane-35).

  5. Should Ozempic Make You Tired? Experts Explain the ... - AOL

    www.aol.com/lifestyle/ozempic-tired-experts...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Perhexiline - Wikipedia

    en.wikipedia.org/wiki/Perhexiline

    Perhexiline (Pexsig) is a prophylactic antianginal agent used primarily in Australia and New Zealand. Perhexiline is thought to act by inhibiting mitochondrial carnitine palmitoyltransferase-1 . This shifts myocardial metabolism from fatty acid to glucose utilisation which results in increased ATP production for the same O 2 consumption and ...

  7. Ranolazine - Wikipedia

    en.wikipedia.org/wiki/Ranolazine

    Ranolazine was approved by the FDA in January 2006, for the treatment of patients with chronic angina as a second-line treatment in addition to other drugs. [13] In 2007 the label was updated to make ranolazine a first-line treatment, alone or with other drugs. [13] In April 2008 ranolazine was approved by the European EMEA for use in angina. [25]

  8. Twilight sleep - Wikipedia

    en.wikipedia.org/wiki/Twilight_sleep

    The campaign dwindled after one of its leaders, Frances X. Carmody, [14] died of hemorrhage giving birth while using twilight sleep, though her husband and doctor asserted that her death was unrelated to the use of twilight sleep. [5] [8]

  9. Breakthrough antidepressants with fewer side effects could ...

    www.aol.com/finance/breakthrough-antidepressants...

    The number of people with depression has reached new highs—and so has antidepressant use. As Americans are increasingly reaching for pharmaceutical solutions for depression—about one in eight ...